Xiaojun Liu

11.1k citations

235 papers · 7.3k · 5 hit papers · h-index 33

Impact in

Oncology top 0.5%
- CAR-T cell therapy research
Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research

Papers in

Molecular Biology 100
- RNA Research and Splicing 14
- RNA modifications and cancer 14
Cancer Research 48
- MicroRNA in disease regulation 23
- Cancer-related molecular mechanisms research 19

Co-authors: Yangbing Zhao (14 shared papers)Carl H. June (13 shared papers)Shuguang Jiang (11 shared papers)Chongyun Fang (6 shared papers)Jiangtao Ren (3 shared papers)Chunxiang Zhang (3 shared papers)Yunhui Cheng (3 shared papers)Jian Yang (2 shared papers)
Journals: Scientific Reports (8 papers)Cancer Research (7 papers)PLoS ONE (6 papers)Oncology Reports (6 papers)BMC Genomics (4 papers)
Partner nations: China United States Australia

In The Last Decade

Xiaojun Liu

217 papers receiving 7.2k citations

Xiaojun Liu's Hit Papers

5 papers align trajectories log scale

A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors 2016 · 420 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2016 Cancer Research
2016 Clinical Cancer Research
2015 Cancer Research
2013 Cancer Immunology Research
2007 Circulation Research

Peers

Countries citing papers authored by Xiaojun Liu

Since Specialization

Citations

This map shows the geographic impact of Xiaojun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojun Liu more than expected).

Fields of papers citing papers by Xiaojun Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojun Liu. The network helps show where Xiaojun Liu may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaojun Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaojun Liu Line = papers co-authored together Xiaojun Liu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 235 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	MicroRNA Expression Signature and Antisense-Mediated Depletion Reveal an Essential Role of MicroRNA in Vascular Neointimal Lesion Formation Circulation Research ·Ruirui Ji, Yunhui Cheng, Junming Yue, Jian Yang, Xiaojun Liu, He Chen, David B. Dean, Chunxiang Zhang Hit paper breakdown →	2007	763
2	Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition Clinical Cancer Research ·Jiangtao Ren, Xiaojun Liu, Chongyun Fang, Shuguang Jiang, Carl H. June, Yangbing Zhao Hit paper breakdown →	2016	738
3	T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans Cancer Immunology Research ·Marcela V. Maus, Andrew R. Haas, Gregory L. Beatty, Steven Μ. Albelda, Bruce L. Levine, Xiaojun Liu, Yangbing Zhao, Michael Kalos, Carl H. June Hit paper breakdown →	2013	476
4	Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice Cancer Research ·Xiaojun Liu, Shuguang Jiang, Chongyun Fang, Shiyu Yang, Devvora Olalere, Edward Pequignot, Alexandria P. Cogdill, Na Li, Melissa Ramones, Brian Granda, Li Zhou, Andreas Loew, Regina M. Young, Carl H. June, Yangbing Zhao Hit paper breakdown →	2015	425
5	A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid Tumors Cancer Research ·Xiaojun Liu, Raghuveer Ranganathan, Shuguang Jiang, Chongyun Fang, Jing Sun, Soyeon Kim, Kheng Newick, Albert Lo, Carl H. June, Yangbing Zhao, Edmund K. Moon Hit paper breakdown →	2016	420
6	Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor Cancer Research ·Yangbing Zhao, Edmund K. Moon, Carmine Carpenito, Chrystal M. Paulos, Xiaojun Liu, Andrea Brennan, Anne Chew, Richard G. Carroll, John Scholler, Bruce L. Levine, Steven Μ. Albelda, Carl H. June	2010	366
7	A versatile system for rapid multiplex genome-edited CAR T cell generation Oncotarget ·Jiangtao Ren, Xuhua Zhang, Xiaojun Liu, Chongyun Fang, Shuguang Jiang, Carl H. June, Yangbing Zhao	2017	315
8	Treatment of Advanced Leukemia in Mice with mRNA Engineered T Cells Human Gene Therapy ·David M. Barrett, Yangbing Zhao, Xiaojun Liu, Shuguang Jiang, Carmine Carpenito, Michael Kalos, Richard G. Carroll, Carl H. June, Stephan A. Grupp	2011	182
9	miR-17-3p Contributes to Exercise-Induced Cardiac Growth and Protects against Myocardial Ischemia-Reperfusion Injury Theranostics ·Jing Shi, Yihua Bei, Xiangqing Kong, Xiaojun Liu, Zhiyong Lei, Tianzhao Xu, Hui Wang, Qinkao Xuan, Ping Chen, Jiahong Xu, Lin Che, Hui Liu, Jiuchang Zhong, Joost P. G. Sluijter, Xinli Li, Anthony Rosenzweig, Junjie Xiao	2017	181
10	A long-acting formulation of a polypeptide drug exenatide in treatment of diabetes using an injectable block copolymer hydrogel Biomaterials ·Kun Li, Lin Yu, Xiaojun Liu, Chang Chen, Qinghua Chen, Jiandong Ding	2013	140
11	Full activation pattern mapping by simultaneous deep brain stimulation and fMRI with graphene fiber electrodes Nature Communications ·Siyuan Zhao, Gen Li, Chuanjun Tong, Wenjing Chen, Puxin Wang, Jiankun Dai, Xuefeng Fu, Zheng Xu, Xiaojun Liu, Linlin Lu, Zhifeng Liang, Xiaojie Duan	2020	104
12	Regimen-Specific Effects of RNA-Modified Chimeric Antigen Receptor T Cells in Mice with Advanced Leukemia Human Gene Therapy ·David M. Barrett, Xiaojun Liu, Shuguang Jiang, Carl H. June, Stephan A. Grupp, Yangbing Zhao	2013	99
13	Blockade of Programmed Death 1 Augments the Ability of Human T Cells Engineered to Target NY-ESO-1 to Control Tumor Growth after Adoptive Transfer Clinical Cancer Research ·Edmund K. Moon, Raghuveer Ranganathan, Evgeniy Eruslanov, Soyeon Kim, Kheng Newick, Shaun O’Brien, Albert Lo, Xiaojun Liu, Yangbing Zhao, Steven Μ. Albelda	2015	96
14	The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis International Journal of Oncology ·Xiaojun Liu, Shoupin Xie, Min Liu, Zhaofeng Chen, Li Wang, Dayan Li, Yongning Zhou	2014	85
15	lncExACT1 and DCHS2 Regulate Physiological and Pathological Cardiac Growth Circulation ·Haobo Li, Lena Trager, Xiaojun Liu, Margaret H. Hastings, Chunyang Xiao, Justin Ralph Baldovino Guerra, Samantha To, Guoping Li, Ashish Yeri, Rodosthenis S. Rodosthenous, Michael G. Silverman, Saumya Das, Amrut V. Ambardekar, Michael R. Bristow, Juan Manuel González‐Rosa, Anthony Rosenzweig	2022	77
16	Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapy Cytotherapy ·David M. Barrett, Nathan Singh, Xiaojun Liu, Shuguang Jiang, Carl H. June, Stephan A. Grupp, Yangbing Zhao	2014	76
17	A highly selective near-infrared fluorescent probe for imaging H₂Se in living cells and in vivo Chemical Science ·Fanpeng Kong, Lihong Ge, Xiaohong Pan, Kehua Xu, Xiaojun Liu, Bo Tang	2015	74
18	Nature of Tumor Control by Permanently and Transiently Modified GD2 Chimeric Antigen Receptor T Cells in Xenograft Models of Neuroblastoma Cancer Immunology Research ·Nathan Singh, Xiaojun Liu, Jessica Hulitt, Shuguang Jiang, Carl H. June, Stephan A. Grupp, David M. Barrett, Yangbing Zhao	2014	65
19	Cold‐inducible RNA‐binding protein (CIRP) regulates target mRNA stabilization in the mouse testis FEBS Letters ·Zhiping Xia, Xinmin Zheng, Hang Zheng, Xiaojun Liu, Zhonghua Yang, Xinghuan Wang	2012	63
20	Generation of Prostate Tumor–Initiating Cells Is Associated with Elevation of Reactive Oxygen Species and IL-6/STAT3 Signaling Cancer Research ·Yi Qu, Anne M. Øyan, Runhui Liu, Yaping Hua, Jigang Zhang, Randi Hovland, Mihaela Popa, Xiaojun Liu, Karl A. Brokstad, Ronald Simon, Anders Molven, Biaoyang Lin, Weidong Zhang, Emmet McCormack, Karl‐Henning Kalland, Xisong Ke	2013	61

About Xiaojun Liu

Xiaojun Liu is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Genetics, having authored 235 papers that have together received 7.3k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (23 papers), Cancer-related molecular mechanisms research (19 papers), CAR-T cell therapy research (15 papers), RNA Research and Splicing (14 papers), RNA modifications and cancer (14 papers), Ferroptosis and cancer prognosis (9 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (9 papers) and Cancer Immunotherapy and Biomarkers (8 papers). The work is most often cited by research in Oncology (3.3k citations), Cancer Research (1.4k citations), Immunology (1.3k citations), Genetics (1.4k citations) and Molecular Biology (3.5k citations). Xiaojun Liu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yangbing Zhao, Carl H. June, Shuguang Jiang, Chongyun Fang, Jiangtao Ren, Chunxiang Zhang, Yunhui Cheng, Jian Yang, Junming Yue and Ruirui Ji. Their work appears in journals such as Scientific Reports, Cancer Research, PLoS ONE, Oncology Reports and BMC Genomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Xiaojun Liu

Impact in

Papers in i

In The Last Decade

Xiaojun Liu

Xiaojun Liu's Hit Papers

Peers

Countries citing papers authored by Xiaojun Liu

Fields of papers citing papers by Xiaojun Liu

All Works

About Xiaojun Liu

Explore authors with similar magnitude of impact

Papers in